Login to Your Account

Rebiotix Seeking to Pioneer Microbiota Restoration

By Marie Powers
Staff Writer

Monday, September 30, 2013
Rebiotix Inc. has sprinted from concept to clinical application in less than two years in pursuit of treatment for gastrointestinal diseases, such as recurring Clostridium difficile infection (CDI), using the human microbiome – the collective genomes of the human microbiota.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription